Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

Fox Business

01 Aug 2026, 20:00 UTC · 3h ago

We are a few years away from bringing back the WOOLLY MAMMOTH, says Colossal Biosciences founder

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

We are a few years away from bringing back the WOOLLY MAMMOTH, says Colossal Biosciences founder

Which stocks this story touches

How each ticker is affected

FOXA+0.10
The company's platform is hosting the interview, though there is no significant financial impact described.

Read original · https://www.youtube.com/watch?v=kul68VmXT9c

Free · No account

Track these names every morning.

Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.

We’ll watch

$FOXA#biotechnology#conservation#deextinction#genetics

Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.

Free forever · one email a day, max · unsubscribe in one click.How it works

How the impact breaks down

Where the story's weight lands

Impact by category

Sector Rotation+0.100

6 related stories

The Motley Fool
2h ago
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?
- biotechnology
Read

We are a few years away f… — FOXA +0.10 | NewsImpactScreener

We are a few years away from bringing back the WOOLLY MAMMOTH, says Colossal Biosciences founder

How each ticker is affected

Track these names every morning.

Impact by category

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

We are a few years away from bringing back the WOOLLY MAMMOTH, says Colossal Biosciences founder

How each ticker is affected

Track these names every morning.

Impact by category

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

Biggest drivers

Most positively impacted

Most negatively impacted

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

Biotech company launches multi-cancer detection test

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Investigation Opened Following Massive Stock Crash

We are a few years away from bringing back the WOOLLY MAMMOTH, says Colossal Biosciences founder

How each ticker is affected

Track these names every morning.

Impact by category

Next reads from the same story arc

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

We are a few years away from bringing back the WOOLLY MAMMOTH, says Colossal Biosciences founder

How each ticker is affected

Track these names every morning.

Impact by category

Next reads from the same story arc

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

Biggest drivers

Most positively impacted

Most negatively impacted

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGS

Biotech company launches multi-cancer detection test

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Investigation Opened Following Massive Stock Crash